Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN)
India flag India · Delayed Price · Currency is INR
132.66
-3.05 (-2.25%)
Oct 21, 2026, 3:29 PM IST

Nath Bio-Genes (India) Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
4,8984,4523,6503,3283,0142,784
Revenue Growth
21.02%21.95%9.70%10.42%8.26%-9.49%
Gross Profit
2,6333,0672,8072,4882,1991,847
Operating Income
543.11487.69471.49467.6458.79345.7
Net Income
456.11416.3386396.19350.11-673.85
Earnings Per Share
22.9921.9120.3120.8518.42-35.46
EPS Growth
2.93%7.85%-2.57%13.16%--

Revenue by Segment

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '25 Mar '24 Mar '23 Mar '22
Trading Activities
380.11456.05357.66295.37228.41
Agriculture Activities
4,0713,1672,9692,7182,555
Total
4,4513,6233,3263,0142,784

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
759.95759.95888.99774.1379.9541.81
Total Debt
1,3851,3851,2251,1031,052929.59
Net Cash (Debt)
-625.06-625.06-336.01-329.36-672.17-887.78
Net Cash Growth
------
Net Cash Per Share
-31.50-32.89-17.68-17.33-35.37-46.72

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
--125.73175.81745.94383.67170.48
Capital Expenditures
--30.05-79.2-267.76-28.81-210.04
Free Cash Flow
--155.7896.61478.18354.85-39.56
Free Cash Flow Growth
---79.80%34.76%--

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
53.76%68.90%76.90%74.78%72.98%66.35%
Operating Margin
11.09%10.96%12.92%14.05%15.22%12.42%
Pretax Margin
10.28%10.40%11.12%12.49%12.00%-22.79%
Profit Margin
9.31%9.35%10.57%11.91%11.62%-24.21%
FCF Margin
--3.50%2.65%14.37%11.77%-1.42%

Dividends

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingOct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Dividend Per Share
2.0002.0002.0002.0002.0002.000
Dividend Per Share Growth
0%0%0%0%0%0%
Dividend Yield
1.51%1.55%1.37%1.15%1.42%0.94%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingOct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
5.905.897.188.357.67-
P/FCF Ratio
--28.696.927.57-
PS Ratio
0.530.550.760.990.891.46